Summary
The duration and extent of cardiac beta-blockade and their relationship to propranolol pharmacokinetics were assessed in nine healthy volunteers. Each subject received 160 mg of regular propranolol (R), 160 mg of sustained-release propranolol (SR) and no drug (control), both as single doses and once daily for 7 days.
After single doses and at steady-state, both products caused a decrease in exercise heart rate for at least 24 h, compared to control. The time course of effect was similar to the time course of serum propranolol concentration. The oral clearance of propranolol decreased from single doses to steady-state for both R and SR; however, the difference achieved statistical significance only for R. These changes were reflected in mean accumulation ratios (AUC steady-state 0–24 h/AUC single dose 0-infinity) of 1.49 and 1.68 for R and SR, respectively.
The pharmacokinetic data are consistent with a decrease in intrinsic hepatic clearance of propranolol, leading to an increase in bioavailability at steady-state. Despite a two-fold difference in the bioavailability of R and SR, there was no difference in the area under the effect-time curve at steady-state.
References
Conover WF (1980) Practical non-parametric statistics, 2nd edn. John Wiley and Sons, New York, NY
Lalonde RL, Pieper JA, Straka RJ, Bottorff MB, Mirvis DM (1987) Pharmacodynamic modeling of propranolol. Clin Pharmacol Ther 41: 156
Lo Man-Wa, Silber B, Riegelman S (1982) An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine. J Chromatogr Sci 183: 126–131
Silber BM, Holford NHG, Riegelman S (1983) Dose dependent elimination of propranolol and its major metabolites in humans. J Pharm Sci 72: 725–732
Wagner JG (1985) Propranolol: Pooled Michaelis-Menten parameters and the effect of input rate on bioavailability. Clin Pharmacol Ther 37: 481–487
Wood AJJ, Carr K, Vestal RE, Belcher S, Wilkinson GR, Shand DG (1978) Direct measurement of propranolol bioavailability during accumulation to steady-state. Br J Clin Pharmacol 6: 345–350
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lalonde, R.L., Pieper, J.A., Straka, R.J. et al. Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state. Eur J Clin Pharmacol 33, 315–318 (1987). https://doi.org/10.1007/BF00637569
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637569